Markets.com Logo

SYNACT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    17.9779$
  • Previous Close
    18.0368$
  • 52 Week Change
    16.14$
  • Day Range
    -0.06$
  • 52 Week High/Low
    7.31$ - 23.45$
  • Dividend Per Share
    --
  • Market cap
    964 M$
  • EPS
    -0.5077
  • Beta
    0.991
  • Volume
    --

About

SYNACT.ST represents shares of SynAct Pharma AB traded on the Nasdaq First North Growth Market Stockholm. SynAct Pharma is a Swedish biotechnology company focused on resolving inflammation through selective activation of melanocortin receptors. Their lead drug candidate, resomelagon, is being developed for the treatment of inflammatory and autoimmune diseases, with a focus on rheumatoid arthritis and idiopathic nephrotic syndrome. Investors can buy and sell SYNACT.ST shares through brokers that provide access to the Nasdaq First North Growth Market.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Company Performance: Financial health, revenue growth, profitability, and debt levels influence investor confidence.

Market Sentiment: Overall investor attitude towards the stock market and specific sectors impacts demand.

Industry Trends: Developments in technology and consumer behavior affecting SynAct Pharma's sector play a role.

Regulatory Changes: New regulations or approvals related to drugs can significantly alter stock value.

Clinical Trial Results: Positive or negative results from clinical trials strongly influence stock prices.

Competition: Actions of competitors, their product launches, or successes affect SynAct Pharma's market position.

Economic Conditions: Broader economic factors like interest rates and inflation can impact investor decisions.

News & Announcements: Company specific announcements such as partnerships or acquisitions.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--